HEADER TRANSFERASE 25-MAY-18 6GMD TITLE THE CRYSTAL STRUCTURE OF CK2ALPHA IN COMPLEX WITH COMPOUND 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 2-329 AND N-TERMINAL EXTENSION COMPND 5 GSMDIEFDDDADDDGSGSGSGSGS; COMPND 6 SYNONYM: CK II ALPHA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHAT2 KEYWDS CK2ALPHA, CK2A, FRAGMENT BASED DRUG DISCOVERY, HIGH CONCENTRATION KEYWDS 2 SCREENING, SELECTIVE ATP COMPETITIVE INHIBITORS, SURFACE ENTROPHY KEYWDS 3 REDUCTION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.BREAR,J.IEGRE,A.NORTH,C.DE FUSCO,K.GEORGIOU,A.LUBIN,L.CARRO,H.SORE, AUTHOR 2 M.HYVONEN,D.SPRING REVDAT 3 17-JAN-24 6GMD 1 REMARK REVDAT 2 20-JUN-18 6GMD 1 JRNL REVDAT 1 06-JUN-18 6GMD 0 JRNL AUTH P.BREAR,A.NORTH,J.IEGRE,K.HADJE GEORGIOU,A.LUBIN,L.CARRO, JRNL AUTH 2 W.GREEN,H.F.SORE,M.HYVONEN,D.R.SPRING JRNL TITL NOVEL NON-ATP COMPETITIVE SMALL MOLECULES TARGETING THE CK2 JRNL TITL 2 ALPHA / BETA INTERFACE. JRNL REF BIOORG. MED. CHEM. V. 26 3016 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29759799 JRNL DOI 10.1016/J.BMC.2018.05.011 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 87868 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 4463 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.70 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.32 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 6390 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3189 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6068 REMARK 3 BIN R VALUE (WORKING SET) : 0.3158 REMARK 3 BIN FREE R VALUE : 0.3755 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.04 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 322 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5495 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 107 REMARK 3 SOLVENT ATOMS : 385 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.14990 REMARK 3 B22 (A**2) : -4.77380 REMARK 3 B33 (A**2) : -2.37610 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.264 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.115 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.108 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.113 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.108 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.916 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5817 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7881 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2054 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 144 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 912 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5817 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 697 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6943 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.94 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.88 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GMD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200010166. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96862 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 88560 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 66.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.88400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5CVH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 112.5MM MES PH 6.5, 35% GLYCEROL REMARK 280 ETHOXYLATE, 180 MM AMMONIUM ACETATE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 166.62900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 166.62900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.36950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 34.42000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.36950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 34.42000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 166.62900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.36950 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 34.42000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 166.62900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.36950 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 34.42000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -22 REMARK 465 SER A -21 REMARK 465 MET A -20 REMARK 465 ASP A -19 REMARK 465 ILE A -18 REMARK 465 GLU A -17 REMARK 465 PHE A -16 REMARK 465 ASP A -15 REMARK 465 ASP A -14 REMARK 465 ASP A -13 REMARK 465 ALA A -12 REMARK 465 ASP A -11 REMARK 465 ASP A -10 REMARK 465 ASP A -9 REMARK 465 GLY A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 SER A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 VAL A 328 REMARK 465 LYS A 329 REMARK 465 GLY B -22 REMARK 465 SER B -21 REMARK 465 MET B -20 REMARK 465 ASP B -19 REMARK 465 ILE B -18 REMARK 465 GLU B -17 REMARK 465 PHE B -16 REMARK 465 ASP B -15 REMARK 465 ASP B -14 REMARK 465 ASP B -13 REMARK 465 ALA B -12 REMARK 465 ASP B -11 REMARK 465 ASP B -10 REMARK 465 ASP B -9 REMARK 465 GLY B -8 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 SER B -5 REMARK 465 GLY B -4 REMARK 465 SER B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 LYS B 329 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 42 -61.94 -98.97 REMARK 500 ASP A 156 40.76 -149.86 REMARK 500 ASP A 175 80.69 49.81 REMARK 500 ALA A 193 168.57 61.83 REMARK 500 ALA A 193 168.30 61.83 REMARK 500 ARG A 195 -59.48 -29.44 REMARK 500 ASP A 210 -157.45 -151.50 REMARK 500 VAL B 42 -60.17 -98.27 REMARK 500 ASP B 156 39.68 -152.88 REMARK 500 ASP B 175 78.03 51.27 REMARK 500 ALA B 193 170.24 57.10 REMARK 500 ALA B 193 169.91 57.10 REMARK 500 ASP B 210 -159.56 -152.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 10 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER A 311 12.32 REMARK 500 SER A 311 13.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 ATP A 403 REMARK 610 ATP B 406 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A8Q A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ATP A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A8Q B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A8Q B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ATP B 406 DBREF 6GMD A 2 329 UNP P68400 CSK21_HUMAN 2 329 DBREF 6GMD B 2 329 UNP P68400 CSK21_HUMAN 2 329 SEQADV 6GMD GLY A -22 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A -21 UNP P68400 EXPRESSION TAG SEQADV 6GMD MET A -20 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -19 UNP P68400 EXPRESSION TAG SEQADV 6GMD ILE A -18 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLU A -17 UNP P68400 EXPRESSION TAG SEQADV 6GMD PHE A -16 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -15 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -14 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -13 UNP P68400 EXPRESSION TAG SEQADV 6GMD ALA A -12 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -11 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -10 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP A -9 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY A -8 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A -7 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY A -6 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A -5 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY A -4 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A -3 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY A -2 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A -1 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY A 0 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A 1 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER A 21 UNP P68400 ARG 21 ENGINEERED MUTATION SEQADV 6GMD GLY B -22 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B -21 UNP P68400 EXPRESSION TAG SEQADV 6GMD MET B -20 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -19 UNP P68400 EXPRESSION TAG SEQADV 6GMD ILE B -18 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLU B -17 UNP P68400 EXPRESSION TAG SEQADV 6GMD PHE B -16 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -15 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -14 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -13 UNP P68400 EXPRESSION TAG SEQADV 6GMD ALA B -12 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -11 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -10 UNP P68400 EXPRESSION TAG SEQADV 6GMD ASP B -9 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY B -8 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B -7 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY B -6 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B -5 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY B -4 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B -3 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY B -2 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B -1 UNP P68400 EXPRESSION TAG SEQADV 6GMD GLY B 0 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B 1 UNP P68400 EXPRESSION TAG SEQADV 6GMD SER B 21 UNP P68400 ARG 21 ENGINEERED MUTATION SEQRES 1 A 352 GLY SER MET ASP ILE GLU PHE ASP ASP ASP ALA ASP ASP SEQRES 2 A 352 ASP GLY SER GLY SER GLY SER GLY SER GLY SER SER GLY SEQRES 3 A 352 PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP VAL ASN SEQRES 4 A 352 THR HIS ARG PRO SER GLU TYR TRP ASP TYR GLU SER HIS SEQRES 5 A 352 VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN LEU VAL SEQRES 6 A 352 ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL PHE GLU SEQRES 7 A 352 ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL VAL LYS SEQRES 8 A 352 ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE LYS ARG GLU SEQRES 9 A 352 ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO ASN ILE SEQRES 10 A 352 ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SER ARG SEQRES 11 A 352 THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN THR ASP SEQRES 12 A 352 PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR ASP ILE SEQRES 13 A 352 ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU ASP TYR SEQRES 14 A 352 CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL LYS PRO SEQRES 15 A 352 HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS LEU ARG SEQRES 16 A 352 LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS PRO GLY SEQRES 17 A 352 GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR PHE LYS SEQRES 18 A 352 GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR ASP TYR SEQRES 19 A 352 SER LEU ASP MET TRP SER LEU GLY CYS MET LEU ALA SER SEQRES 20 A 352 MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY HIS ASP SEQRES 21 A 352 ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL LEU GLY SEQRES 22 A 352 THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR ASN ILE SEQRES 23 A 352 GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY ARG HIS SEQRES 24 A 352 SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER GLU ASN SEQRES 25 A 352 GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE LEU ASP SEQRES 26 A 352 LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU THR ALA SEQRES 27 A 352 ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR VAL VAL SEQRES 28 A 352 LYS SEQRES 1 B 352 GLY SER MET ASP ILE GLU PHE ASP ASP ASP ALA ASP ASP SEQRES 2 B 352 ASP GLY SER GLY SER GLY SER GLY SER GLY SER SER GLY SEQRES 3 B 352 PRO VAL PRO SER ARG ALA ARG VAL TYR THR ASP VAL ASN SEQRES 4 B 352 THR HIS ARG PRO SER GLU TYR TRP ASP TYR GLU SER HIS SEQRES 5 B 352 VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR GLN LEU VAL SEQRES 6 B 352 ARG LYS LEU GLY ARG GLY LYS TYR SER GLU VAL PHE GLU SEQRES 7 B 352 ALA ILE ASN ILE THR ASN ASN GLU LYS VAL VAL VAL LYS SEQRES 8 B 352 ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE LYS ARG GLU SEQRES 9 B 352 ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY PRO ASN ILE SEQRES 10 B 352 ILE THR LEU ALA ASP ILE VAL LYS ASP PRO VAL SER ARG SEQRES 11 B 352 THR PRO ALA LEU VAL PHE GLU HIS VAL ASN ASN THR ASP SEQRES 12 B 352 PHE LYS GLN LEU TYR GLN THR LEU THR ASP TYR ASP ILE SEQRES 13 B 352 ARG PHE TYR MET TYR GLU ILE LEU LYS ALA LEU ASP TYR SEQRES 14 B 352 CYS HIS SER MET GLY ILE MET HIS ARG ASP VAL LYS PRO SEQRES 15 B 352 HIS ASN VAL MET ILE ASP HIS GLU HIS ARG LYS LEU ARG SEQRES 16 B 352 LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR HIS PRO GLY SEQRES 17 B 352 GLN GLU TYR ASN VAL ARG VAL ALA SER ARG TYR PHE LYS SEQRES 18 B 352 GLY PRO GLU LEU LEU VAL ASP TYR GLN MET TYR ASP TYR SEQRES 19 B 352 SER LEU ASP MET TRP SER LEU GLY CYS MET LEU ALA SER SEQRES 20 B 352 MET ILE PHE ARG LYS GLU PRO PHE PHE HIS GLY HIS ASP SEQRES 21 B 352 ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS VAL LEU GLY SEQRES 22 B 352 THR GLU ASP LEU TYR ASP TYR ILE ASP LYS TYR ASN ILE SEQRES 23 B 352 GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU GLY ARG HIS SEQRES 24 B 352 SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SER GLU ASN SEQRES 25 B 352 GLN HIS LEU VAL SER PRO GLU ALA LEU ASP PHE LEU ASP SEQRES 26 B 352 LYS LEU LEU ARG TYR ASP HIS GLN SER ARG LEU THR ALA SEQRES 27 B 352 ARG GLU ALA MET GLU HIS PRO TYR PHE TYR THR VAL VAL SEQRES 28 B 352 LYS HET ACT A 401 4 HET A8Q A 402 18 HET ATP A 403 19 HET ACT B 401 4 HET ACT B 402 4 HET ACT B 403 4 HET A8Q B 404 18 HET A8Q B 405 18 HET ATP B 406 18 HETNAM ACT ACETATE ION HETNAM A8Q [3-CHLORANYL-4-(2-PROPAN-2-YLPHENYL) HETNAM 2 A8Q PHENYL]METHYLAZANIUM HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 3 ACT 4(C2 H3 O2 1-) FORMUL 4 A8Q 3(C16 H19 CL N 1+) FORMUL 5 ATP 2(C10 H16 N5 O13 P3) FORMUL 12 HOH *385(H2 O) HELIX 1 AA1 PRO A 20 ASP A 25 1 6 HELIX 2 AA2 TYR A 26 HIS A 29 5 4 HELIX 3 AA3 ASN A 35 ASP A 37 5 3 HELIX 4 AA4 LYS A 74 ARG A 89 1 16 HELIX 5 AA5 ASP A 120 TYR A 125 1 6 HELIX 6 AA6 GLN A 126 LEU A 128 5 3 HELIX 7 AA7 THR A 129 MET A 150 1 22 HELIX 8 AA8 LYS A 158 HIS A 160 5 3 HELIX 9 AA9 SER A 194 LYS A 198 5 5 HELIX 10 AB1 GLY A 199 VAL A 204 1 6 HELIX 11 AB2 TYR A 211 PHE A 227 1 17 HELIX 12 AB3 ASP A 237 GLY A 250 1 14 HELIX 13 AB4 GLY A 250 TYR A 261 1 12 HELIX 14 AB5 PRO A 267 LEU A 273 1 7 HELIX 15 AB6 ARG A 280 VAL A 285 5 6 HELIX 16 AB7 ASN A 289 VAL A 293 5 5 HELIX 17 AB8 SER A 294 LEU A 305 1 12 HELIX 18 AB9 ASP A 308 ARG A 312 5 5 HELIX 19 AC1 THR A 314 GLU A 320 1 7 HELIX 20 AC2 HIS A 321 TYR A 325 5 5 HELIX 21 AC3 PRO B 20 ASP B 25 1 6 HELIX 22 AC4 TYR B 26 HIS B 29 5 4 HELIX 23 AC5 ASN B 35 ASP B 37 5 3 HELIX 24 AC6 LYS B 74 ARG B 89 1 16 HELIX 25 AC7 ASP B 120 LEU B 128 1 9 HELIX 26 AC8 THR B 129 MET B 150 1 22 HELIX 27 AC9 LYS B 158 HIS B 160 5 3 HELIX 28 AD1 SER B 194 LYS B 198 5 5 HELIX 29 AD2 GLY B 199 VAL B 204 1 6 HELIX 30 AD3 TYR B 211 ARG B 228 1 18 HELIX 31 AD4 ASP B 237 GLY B 250 1 14 HELIX 32 AD5 GLY B 250 TYR B 261 1 12 HELIX 33 AD6 ASP B 266 ASN B 270 5 5 HELIX 34 AD7 ARG B 280 VAL B 285 5 6 HELIX 35 AD8 SER B 294 LEU B 305 1 12 HELIX 36 AD9 ASP B 308 ARG B 312 5 5 HELIX 37 AE1 THR B 314 GLU B 320 1 7 HELIX 38 AE2 HIS B 321 TYR B 325 5 5 SHEET 1 AA1 5 TYR A 39 ARG A 47 0 SHEET 2 AA1 5 SER A 51 ASN A 58 -1 O GLU A 55 N VAL A 42 SHEET 3 AA1 5 LYS A 64 LEU A 70 -1 O VAL A 65 N ALA A 56 SHEET 4 AA1 5 THR A 108 GLU A 114 -1 O PHE A 113 N VAL A 66 SHEET 5 AA1 5 LEU A 97 ASP A 103 -1 N ASP A 99 O VAL A 112 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O ARG A 172 N MET A 163 SHEET 1 AA4 5 TYR B 39 ARG B 47 0 SHEET 2 AA4 5 SER B 51 ASN B 58 -1 O GLU B 55 N VAL B 42 SHEET 3 AA4 5 LYS B 64 LEU B 70 -1 O VAL B 65 N ALA B 56 SHEET 4 AA4 5 THR B 108 GLU B 114 -1 O LEU B 111 N LYS B 68 SHEET 5 AA4 5 LEU B 97 ASP B 103 -1 N ASP B 99 O VAL B 112 SHEET 1 AA5 2 ILE B 152 MET B 153 0 SHEET 2 AA5 2 GLU B 180 PHE B 181 -1 O GLU B 180 N MET B 153 SHEET 1 AA6 2 VAL B 162 ASP B 165 0 SHEET 2 AA6 2 LYS B 170 LEU B 173 -1 O ARG B 172 N MET B 163 CISPEP 1 GLU A 230 PRO A 231 0 -8.65 CISPEP 2 GLU B 230 PRO B 231 0 -10.22 SITE 1 AC1 4 ARG A 80 ARG A 155 ASN A 189 HOH A 558 SITE 1 AC2 12 ASN A 118 THR A 119 PHE A 121 LEU A 124 SITE 2 AC2 12 LEU A 128 TYR A 136 ILE A 140 PRO A 159 SITE 3 AC2 12 VAL A 162 MET A 221 MET A 225 HOH A 613 SITE 1 AC3 7 VAL A 53 VAL A 66 GLU A 114 VAL A 116 SITE 2 AC3 7 ILE A 174 HOH A 501 HOH A 572 SITE 1 AC4 4 ARG B 80 ARG B 155 LEU B 178 HOH B 611 SITE 1 AC5 4 HIS B 276 SER B 277 LYS B 279 HOH B 652 SITE 1 AC6 5 ARG B 195 TYR B 196 HIS B 234 GLY B 235 SITE 2 AC6 5 HOH B 519 SITE 1 AC7 11 ASN B 118 PHE B 121 LEU B 124 TYR B 136 SITE 2 AC7 11 ILE B 140 PRO B 159 VAL B 162 MET B 221 SITE 3 AC7 11 MET B 225 HOH B 619 HOH B 624 SITE 1 AC8 9 GLN B 36 ASP B 37 TYR B 39 LEU B 41 SITE 2 AC8 9 ILE B 69 ASP B 103 THR B 108 ALA B 110 SITE 3 AC8 9 HOH B 582 SITE 1 AC9 9 LEU B 45 VAL B 53 VAL B 66 ILE B 95 SITE 2 AC9 9 GLU B 114 VAL B 116 MET B 163 ILE B 174 SITE 3 AC9 9 HOH B 566 CRYST1 64.739 68.840 333.258 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015447 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014526 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003001 0.00000